Vivitrol 380 MG vial-diluents
Ended Awarded Last action
- Contract number
- SPE2DR26F1T43
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,229
Award facts
- Contract value 100% obligated
- $6,229.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,229.24 delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed-price contract with an ultimate completion date of January 8, 2026, and was awarded without a set-aside designation through competitive procurement. The products will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Vivitrol (naltrexone extended-release injection) is a medication used in the treatment of opioid and alcohol use disorders within military and veteran healthcare settings. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has consistently demonstrated capability in fulfilling federal medical procurement requirements through its extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency. The company's broader contract awards span diverse therapeutic domains including specialty medications, vaccines, and critical care materials, positioning it as a critical vendor for federal medical supply chains serving military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F1T43?
SPE2DR26F1T43 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F1T43 worth?
The government has obligated $6,229 on SPE2DR26F1T43.
Is contract SPE2DR26F1T43 an order under another contract?
Yes. SPE2DR26F1T43 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1T43 competed?
The extent of competition for SPE2DR26F1T43 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award